Literature DB >> 20947358

An intraoperatively moulded PMMA prostheses like spacer for two-stage revision of infected total knee arthroplasty.

Sandro Kohl1, Dimitrios S Evangelopoulos, Hendrik Kohlhof, Andreas Krueger, Maximilian Hartel, Christoph Roeder, Stefan Eggli.   

Abstract

We report a series of 16 consecutive total knee arthroplasty (TKA) revision procedures for deep infection, treated with a newly developed intraoperatively moulded PMMA cement-prostheses-like spacer (CPLS). The standard treatment consisted of a two-stage protocol with initial explantation of the infected components combined with radical debridement, followed by implantation of a temporary cement spacer and final reimplantation of a new TKA. A sterilizeable Teflon tapered aluminium mould was developed for production of a custom made CPLS during the intervention. Stable implantation of the CPLS was achieved with a second cementation, allowing for correct alignment and ligament balancing. The spacer remained 3.5 months on average until reimplantation of a TKA occurred. At time of reimplantation, patients had an average KSS score of 84.44 points with an average flexion capacity of 102°. There was no recurrent infection during the study period of minimum 2 years. With this new technique, a low friction articulation with good stability, high comfort and a better range of motion compared to handcrafted spacers was achieved. The use of this spacer is a time sparing, cheap and convenient option in 2-stage TKA revision.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947358     DOI: 10.1016/j.knee.2010.09.002

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  9 in total

1.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

Review 2.  Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies.

Authors:  Mitchell C Birt; David W Anderson; E Bruce Toby; Jinxi Wang
Journal:  J Orthop       Date:  2016-10-26

3.  Hot spots and trends in knee revision research since the 21st century: a bibliometric analysis.

Authors:  Kelei Zhai; Weifeng Ma; Tao Huang
Journal:  Ann Transl Med       Date:  2021-03

4.  Revision of infected total knee arthroplasty: two-stage reimplantation using an antibiotic-impregnated static spacer.

Authors:  Antonio Silvestre; Fernando Almeida; Pablo Renovell; Elena Morante; Raúl López
Journal:  Clin Orthop Surg       Date:  2013-08-20

5.  Antibiotic bone cement's effect on infection rates in primary and revision total knee arthroplasties.

Authors:  Donald Kleppel; Jacob Stirton; Jiayong Liu; Nabil A Ebraheim
Journal:  World J Orthop       Date:  2017-12-18

Review 6.  Are Static Spacers Superior to Articulated Spacers in the Staged Treatment of Infected Primary Knee Arthroplasty? A Systematic Review and Meta-Analysis.

Authors:  Michele Fiore; Andrea Sambri; Matteo Filippini; Lorenzo Morante; Claudio Giannini; Azzurra Paolucci; Claudia Rondinella; Renato Zunarelli; Pierluigi Viale; Massimiliano De Paolis
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

Review 7.  A systematic review of the evidence for single stage and two stage revision of infected knee replacement.

Authors:  James P M Masters; Nicholas A Smith; Pedro Foguet; Mike Reed; Helen Parsons; Andrew P Sprowson
Journal:  BMC Musculoskelet Disord       Date:  2013-07-29       Impact factor: 2.362

8.  The cement prosthesis-like spacer: an intermediate halt on the road to healing.

Authors:  Sufian S Ahmad; Kim Huber; Dimitrios S Evangelopoulos; Barbara Kleer; Hendrik Kohlhof; Michael Schär; Stefan Eggli; Sandro Kohl
Journal:  ScientificWorldJournal       Date:  2013-09-30

9.  Loading capacity of dynamic knee spacers: a comparison between hand-moulded and COPAL spacers.

Authors:  Sook-Yee Chong; Lu Shen; Sandra Frantz
Journal:  BMC Musculoskelet Disord       Date:  2019-12-21       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.